Methionine sulfoximine intensifies cancer anorexia.
Consistent anorexia was first observed 33 days after inoculating Fischer 344 rats with methylcholanthrene-induced sarcoma. Daily treatment of a similar group of rats with the glutamine synthetase inhibitor, methionine sulfoximine, elicited significant reductions of feeding by day 29 at a dose that had no effect on nontumor-bearing rats. Blood concentrations of ammonia were elevated in both groups of tumor-bearing rats and brain ammonia level was increased in the methionine sulfoximine-treated tumor-bearing rats. Forebrain concentrations of tyrosine, tryptophan, DOPAC and 5-HIAA were elevated in both groups of tumor-bearing rats. Since ammonia is detoxified through the glutamine synthetase reaction, these results suggest that blood and brain ammonia concentrations are more important than the neurochemical consequences of ammonia detoxification for the etiology of cancer anorexia.
Chance
W T
WT
Department of Surgery, University of Cincinnati Medical Center, OH.
Zhang
F S
FS
Fischer
J E
JE
D000641:Ammonia / Q000097:blood; D000818:Animals; D000855:Anorexia / Q000139:chemically induced / Q000209:etiology / Q000523:psychology*; D015306:Biogenic Monoamines / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D008297:Male; D008717:Methionine Sulfoximine / Q000494:pharmacology*; D008748:Methylcholanthrene; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000150:complications*; D018377:Neurotransmitter Agents / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344; D012513:Sarcoma, Experimental / Q000139:chemically induced / Q000150:complications*
D015306:Biogenic Monoamines; D018377:Neurotransmitter Agents; D008717:Methionine Sulfoximine; D008748:Methylcholanthrene; D000641:Ammonia